Salesforce (CRM) announced that Takeda has selected Salesforce Life Sciences Cloud for Customer Engagement to strengthen its involvement with healthcare professionals seamlessly. The company will leverage Salesforce’s deeply unified platform, including Agentforce and Data Cloud, to deploy personalized AI agents, supporting operations from medical to commercial and patient support functions. “Takeda is an outstanding leader in the industry, aspiring to create better health for people and a brighter future for the world,” Frank Defesche, SVP & GM, Life Sciences at Salesforce. “Now, with Life Sciences Cloud for Customer Engagement, we’ll help Takeda improve provider and patient engagement and scale the impact of every team member.”

Confident Investing Starts Here:

Easily unpack a company's performance  with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox  with TipRanks' Smart Value Newsletter

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on CRM:

Disclaimer & DisclosureReport an Issue

Salesforce’s Stable Position Amidst Evolving Industry Dynamics: A Hold Recommendation “Time Is Running Out,” as Analysts Project Strong Gains for Salesforce Stock (NYSE:CRM) Microsoft (MSFT) Agrees to Unbundle Office Suite in Europe Positive Outlook for Salesforce Driven by Strong Data Solutions and Promising Agentforce Growth Jeffrey Smith’s Starboard Value buys Qorvo, cuts Pfizer in Q1

View Comments